Crossmark

Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN)

Crossref DOI link: https://doi.org/10.1007/s00520-025-09528-0

Published Online: 2025-05-20

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wewala, Navin

Kim, Yujin

Sharples, Katrina

Benge, Sarah

Cartwright, Robert

Tan, Alvin

Clement, Louise

Huang, Ying

Wilson, Sheridan

Kuper-Hommel, Marion

Barton, Sarah

Jones, Joanna

Bremer, Louise

Hari Dass, Prashanth

Wrigley, Abbey

Findlay, Michael

Isaacs, Richard
License Information

Text and Data Mining valid from 2025-05-20

Version of Record valid from 2025-05-20
More Information

Article History

Received: 29 January 2024

Accepted: 6 May 2025

First Online: 20 May 2025

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol and all amendments were approved by a New Zealand Health and Disabilities Ethics Committee at all participating centres.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below